What we do
Fundraising
We are providing our expertise to organize your equity financing from Series A to an Exit, Trade sale, or IPO. Our investor network covers all continents, Europe, North America, and Asia, with the most selective and largest investors in the healthcare industry.
Our goal is to ensure that your company not only raises the capital it needs, but also establishes a strong, long-term partnership with your investors.
DEBT
We are providing our expertise to secure debt financing for your business by providing comprehensive support throughout the process.
Our structured approach to working with debt providers ensures that we identify and target the most appropriate funding options for your needs.
SECONDARY OFFERING
We provide expert advice to companies undertaking secondary offerings to ensure successful execution.
« Thank you Agile Capital Markets for your incredible work, professionalism, and unwavering support! You deserve much credit for this oversubscribed fundraising and I cannot recommend you enough to other healthcare startups looking to raise funds! »
CEO, Discure Technologies
Mergers & Acquisitions
Whether buy-side or sell-side, our M&A activities are based on our deep understanding of the healthcare industry. We have developed a network of contacts from C-Level within companies to BusDev & Licensing teams with a global reach including all continents. Our full service offering covers all aspects of the M&A process from target identification to closing. We work with shareholders as necessary to define optimal strategies.
In our interactions with potential buyers, we conduct a global search, mapping potential interest across the industry and among private equity funds.
At closing, we develop bid/offer strategies to optimize timing and maximize value. We negotiate terms in the best interests of shareholders and provide clear and effective communication throughout the process to ensure a successful transaction.
Mergers & Acquisitions
Buy-side or sell-side mandates, our M&A activity is based on our deep understanding of the healthcare industry. From C-Level contacts within Corporates and their BusDev & Licensing teams through a valuation process of our clients
Our services include the preparation of key marketing documents, including teasers, one-pagers and confidential investment memorandums. We also manage the data room, ensuring that all relevant information is organized and easily accessible.
To ensure accurate valuation, we develop multiple valuation models that are aligned with shareholder expectations and benchmarked against industry exits. We engage with shareholders as necessary to define the optimal strategies.
In our interactions with potential buyers, we conduct a global search, mapping potential interest across the industry and among private equity funds. We assess each buyer’s ability to execute the transaction, approach them selectively, manage confidentiality agreements and coordinate face-to-face meetings with management, providing detailed feedback throughout.
At closing, we design bid/offer strategies to optimize timing and maximize value. We analyze, co-draft and negotiate term sheets in the best interests of shareholders, ensuring clear and effective communication throughout the process to ensure a successful deal.
Licensing
OUT-LICENSING
For out-licensing, we leverage our extensive network of C-level contacts to directly connect with top decision-makers in the healthcare industry. Our hands-on approach ensures your assets are positioned with key players to maximize value and achieve strategic goals.
IN-LICENSING
As a team of scientists and industry experts, we understand the complexities of the healthcare sector. We leverage our analytical expertise to identify the most suitable assets that align with your strategic goals. Through our extensive network of KOLs, startups, and leaders within the industry, we provide tailored solutions to meet your objectives.
With Agile, your licensing deals benefit from deep industry connections and scientific insight, delivering the best possible outcomes for your business.
« Fundraising is a long journey with lots of ups and downs and Agile Capital Markets has been an incredible and hard-working sparring partner who stood next to us at every moment until the conclusion of a deal that was far beyond our expectations. »
CEO, Biophta
Investors services
FOR GENERAL PARTNERS (GPs) – FUNDRAISING SUPPORT
We assist General Partners in raising funds by providing strategic guidance and access to a broad network of institutional investors. Our services include:
- Fundraising Strategy: Helping GPs craft compelling investment stories and positioning their funds for success.
- Investor Outreach: Leveraging our extensive network to connect GPs with potential Limited Partners.
- Due Diligence Support: Assisting in the preparation of necessary documentation and responding to investor inquiries throughout the fundraising process.
FOR LIMITED PARTNERS (LPs) – CAPITAL ALLOCATION ADVISORY
We provide expert guidance to Limited Partners on capital allocation, with a particular focus on healthcare funds. Our LP services cover:
- Fund Selection: Advising LPs on the technical, scientific, and financial aspects of selecting the most promising healthcare-focused funds.
- Capital Allocation Strategy: Developing tailored strategies to optimize the deployment of capital across healthcare funds and portfolios.
- Performance Analysis: Evaluating and providing insights into the performance of healthcare funds in which LPs are already invested, helping them to make informed decisions on future allocations.
FOR PORTFOLIO COMPANIES – STRATEGIC ADVISORY
We offer specialized advisory services to the portfolio companies of Limited Partners, supporting their growth and strategic initiatives. Our services include:
- Fundraising for Growth: Assisting portfolio companies in securing the capital needed to fuel their expansion through equity and debt financing.
- M&A Advisory (Sell-Side and Buy-Side): Providing guidance on mergers and acquisitions, whether your company is looking to sell, acquire, or consolidate through a build-up strategy.
- Licensing Transactions: Supporting companies in structuring and executing licensing deals to unlock additional value from their intellectual property and technologies.
With our in-depth understanding of the healthcare landscape and financial markets, we are committed to helping both investors and portfolio companies achieve their strategic objectives.